Clinical Trial: A Study of QL1706 in Combination with Lenvatinib and Chemotherapy for Advanced First-Line Intrahepatic Cholangiocarcinoma in Patients Aged 60 Years or Older (China)

Posted On: 2026-11-06

China, Nov. 6 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'A Study of QL1706 in Combination with Lenvatinib and Chemotherapy for Advanced First-Line Intrahepatic Cholangiocarcinoma in Patients Aged 60 Years or Older'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600136062

Registration Time: 2026/11/05

Type: Interventional study

Primary Sponsor: Hunan Provincial People's Hospital

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=351132

Published by HT Digital Content Services with permission from Health Daily Digest....

Click here to read full article from source

To read the full article or to get the complete feed from this publication, please Contact Us.

Exclusive

Category

Source

Publication

Location

Clinical Trial: A Study of QL1706 in Combination with Lenvatinib and Chemotherapy for Advanced First-Line Intrahepatic Cholangiocarcinoma in Patients Aged 60 Years or Older (China)